Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

VRPX Virpax Pharmaceuticals

1.160
+0.030+2.65%
Trading Session 09/28 10:44 ET
High
1.160
Open
1.150
Turnover
1.01K
Low
1.150
Pre Close
1.130
Volume
881.00
Market Cap
13.59M
P/E(TTM)
Loss
52wk High
5.620
Shares
11.71M
P/E(Static)
Loss
52wk Low
1.100
Float Cap
8.86M
Bid/Ask %
81.82%
Historical High
36.000
Shs Float
7.64M
Volume Ratio
0.12
Historical Low
1.100
Dividend TTM
--
Div Yield TTM
--
P/B
0.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
0.89%
Avg Price
1.150
Lot Size
1
Float Cap
8.86M
Bid/Ask %
81.82%
Historical High
36.000
Shs Float
7.64M
Volume Ratio
0.12
Historical Low
1.100
Dividend TTM
--
P/B
0.50
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
0.89%
Avg Price
1.150
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
CEO: Mr. Anthony Mack, M.B.A.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...